Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AXON ENTERPRISE, INC. Director's Dealing 2023

Mar 29, 2023

29987_dirs_2023-03-28_49ec9dcb-5585-49fe-8d03-45ee20a443e8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AXON ENTERPRISE, INC. (AXON)
CIK: 0001069183
Period of Report: 2023-03-24

Reporting Person: SMITH PATRICK W (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-27 Common Stock M 57863 $218.59 Acquired 2806019 Direct
2023-03-27 Common Stock S 5408 $216.5151 Disposed 2800611 Direct
2023-03-27 Common Stock S 16993 $217.5545 Disposed 2783618 Direct
2023-03-27 Common Stock S 5019 $218.3568 Disposed 2778599 Direct
2023-03-27 Common Stock S 4157 $218.3568 Disposed 2774442 Direct
2023-03-27 Common Stock S 2270 $219.4678 Disposed 2772172 Direct
2023-03-27 Common Stock S 428 $220.1403 Disposed 2771744 Direct
2023-03-28 Common Stock M 66076 $215.60 Acquired 2837820 Direct
2023-03-28 Common Stock S 27963 $215.3978 Disposed 2809857 Direct
2023-03-28 Common Stock S 3332 $216.0666 Disposed 2806525 Direct
2023-03-28 Common Stock S 1742 $216.0666 Disposed 2804783 Direct
2023-03-28 Common Stock S 4689 $217.2893 Disposed 2800094 Direct
2023-03-28 Common Stock S 1393 $218.0887 Disposed 2798701 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-24 Employee Stock Option $28.58 A 530488 Acquired 2028-02-28 Common Stock (530488) Direct
2023-03-27 Employee Stock Option $28.58 M 6059 Disposed 2028-02-28 Common Stock (6059) Direct
2023-03-27 Employee Stock Option $28.58 M 51804 Disposed 2028-02-28 Common Stock (51804) Direct
2023-03-28 Employee Stock Option $28.58 M 66076 Disposed 2028-02-28 Common Stock (66076) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2022.

F2: Securities disposed represent securities sold to settle the reporting person's tax liability and exercise price pursuant to a filed Rule 10b5-1 plan. The remainder of the shares, with the exception of those reported on this Form 4, are subject to a 2.5 year holding period.

F3: The transaction was executed in multiple trades at prices ranging from $215.90 to $216.89. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: The transaction was executed in multiple trades at prices ranging from $216.90 to $217.89. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: The transaction was executed in multiple trades at prices ranging from $217.90 to $218.89. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan.

F7: The transaction was executed in multiple trades at prices ranging from $218.90 to $219.68. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: The transaction was executed in multiple trades at prices ranging from $219.93 to $220.36. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: The transaction was executed in multiple trades at prices ranging from $214.78 to $215.77. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F10: The transaction was executed in multiple trades at prices ranging from $215.78 to $216.67. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: The transaction was executed in multiple trades at prices ranging from $216.78 to $217.76. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: The transaction was executed in multiple trades at prices ranging from $217.81 to $218.72. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: The transaction consists of performance-based restricted stock options granted on February 26, 2018 (which was approved by shareholders and became effective on May 24, 2018) for the achievement of the eleventh tranche of the CEO Performance Award for which the performance conditions were determined to have been certified by the Compensation Committee on the transaction date. The options for this tranche vested on March 24, 2023. Once the options are exercised, the shares are subject to a 2.5 year minimum holding period, excluding shares sold or made available to sell to cover taxes.